vTv Therapeutics (VTVT) News Today $15.46 -0.97 (-5.90%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period vTv Therapeutics (NASDAQ:VTVT) adds US$9.5m to market cap in the past 7 days, though investors from five years ago are still down 71%November 17, 2024 | finance.yahoo.comvTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate UpdateNovember 13, 2024 | markets.businessinsider.comVTv, OnKure Terminate Cellular Drug Licensing AgreementOctober 25, 2024 | marketwatch.comvTv Therapeutics Faces License Agreement TerminationOctober 25, 2024 | markets.businessinsider.comvTv Therapeutics (NASDAQ:VTVT) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comvTv Therapeutics (NASDAQ:VTVT) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comWe're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn RateAugust 16, 2024 | finance.yahoo.comVTVT Stock Earnings: vTv Therapeutics Reported Results for Q2 2024August 9, 2024 | investorplace.comvTv Therapeutics Inc.: vTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate UpdateAugust 9, 2024 | finanznachrichten.devTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate UpdateAugust 8, 2024 | globenewswire.comvTv Therapeutics' stock plunges after FDA pauses High Point company's diabetes drug developmentAugust 1, 2024 | bizjournals.comWhy Is vTv Therapeutics (VTVT) Stock Down 46% Today?July 29, 2024 | investorplace.comvTv Therapeutics Inc.: vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical HoldJuly 28, 2024 | finanznachrichten.deStocks to Watch: vTv Therapeutics, BJ's Restaurants, Warner Bros. DiscoveryJuly 26, 2024 | marketwatch.comVTv Therapeutics's Cadisegliatin Program For Type 1 Diabetes Placed On Clinical Hold, Stock TanksJuly 26, 2024 | markets.businessinsider.comVTv Therapeutics' Cadisegliatin Clinical Program Put On Hold By FDAJuly 26, 2024 | marketwatch.comvTv Therapeutics Shares Tumble After FDA Pauses Diabetes-Treatment Study >VTVTJuly 26, 2024 | marketwatch.comvTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical HoldJuly 26, 2024 | globenewswire.com5VT0.MU,0P0001EVLU,0 (5VT0.MU)July 23, 2024 | sg.finance.yahoo.comVTV THERAPEUT. A NEW O.N. (5VT0.BE)July 23, 2024 | sg.finance.yahoo.comvTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50 Day Moving Average of $22.15vTv Therapeutics (NASDAQ:VTVT) Shares Pass Below Fifty Day Moving Average of $22.15July 11, 2024 | marketbeat.comvTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 DiabetesJune 24, 2024 | globenewswire.comCANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETINGMay 28, 2024 | prnewswire.comShareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years agoMay 27, 2024 | finance.yahoo.comvTv Therapeutics (NASDAQ:VTVT) Stock Passes Above 50-Day Moving Average of $24.72vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Above 50 Day Moving Average of $24.72May 22, 2024 | marketbeat.comvTv Therapeutics Inc.: vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate UpdateMay 11, 2024 | finanznachrichten.deVTVT Stock Earnings: vTv Therapeutics Reported Results for Q1 2024May 10, 2024 | investorplace.comvTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate UpdateMay 9, 2024 | globenewswire.comCANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMITMarch 19, 2024 | finance.yahoo.comvTv Therapeutics Inc.: vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate UpdateMarch 13, 2024 | finanznachrichten.devTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate UpdateMarch 13, 2024 | globenewswire.comvTv Therapeutics starts phase 3 trial for diabetes drugMarch 6, 2024 | investing.comThe Top 3 Healthcare Stocks to Buy on Weakness in 2024March 4, 2024 | investorplace.comvTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 DiabetesMarch 4, 2024 | globenewswire.comvTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare ConferenceMarch 1, 2024 | globenewswire.comvTv Therapeutics' stock doubles after raising $51 million from health care investors including JDRFFebruary 29, 2024 | bizjournals.comWhy Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today?February 28, 2024 | msn.comvTv Therapeutics Inc. (VTVT)February 28, 2024 | finance.yahoo.comNasdaq Down 50 Points; US Crude Stocks Rise By 4.2M BarrelsFebruary 28, 2024 | markets.businessinsider.comVTv Therapeutics Shares Surge on $51 Million Private PlacementFebruary 28, 2024 | marketwatch.comTrading was temporarily halted for "VTVT" at 11:02 AM with a stated reason of "LULD pause." Trading set to resume at 11:02 AM. February 28, 2024 | marketbeat.comTrading was temporarily halted for "VTVT" at 11:02 AM with a stated reason of "LULD pause."February 28, 2024 | marketbeat.comTrading was temporarily halted for "VTVT" at 11:02 AM with a stated reason of "LULD pause."February 28, 2024 | marketbeat.comvTv Therapeutics Inc. Cl AFebruary 28, 2024 | wsj.comvTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D FundFebruary 28, 2024 | finance.yahoo.comvTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D FundFebruary 28, 2024 | globenewswire.comCANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCEFebruary 22, 2024 | prnewswire.comvTv Therapeutics Inc (VTVT)January 31, 2024 | uk.investing.comvTv Therapeutics Inc - Ordinary Shares - Class ANovember 27, 2023 | money.usnews.comvTv Therapeutics regains compliance with Nasdaq after 1-for-40 reverse stock splitNovember 21, 2023 | bizjournals.com Get vTv Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] VTVT Media Mentions By Week VTVT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VTVT News Sentiment▼0.360.45▲Average Medical News Sentiment VTVT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VTVT Articles This Week▼10▲VTVT Articles Average Week Get vTv Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LUMO News CRBP News OPT News ENTA News ADCT News ZURA News CMPX News HRTX News TNYA News INZY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VTVT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
